You are here

Technology

An analysis of two databases found that measuring frailty could help predict mortality and functional status at six months or later after older adults undergo cardiac surgery.

Recent Headlines

Theranos CEO reveals new device, refuses to discuss company’s issues

Theranos founder and CEO Elizabeth Holmes announced the company had developed a blood-testing device that is not yet FDA-approved that she said can run tests from a finger prick, the Wall Street Journal reports. Holmes, who spoke on August 1 at the American Association for Clinical Chemistry, did not discuss her company’s recent issues with the federal government.

Making Sense of Analytics: The Search for Answers Starts with Asking the Right Questions

Cardiovascular information technology analytics offer opportunities to improve care, reduce costs and deliver better healthcare experiences for patients. 

Healthcare’s IT Priority: Interoperability Is the New Meaningful Use

Medicare’s decision to get “deadly serious” about interoperability is an invitation for cardiologists to work with their medical societies, vendors and office staff.

Theranos CEO Elizabeth Holmes to speak at clinical chemistry conference

Theranos CEO Elizabeth Holmes is expected to speak at the American Association for Clinical Chemistry’s annual meeting on Aug. 1 in Philadelphia and present data on the embattled company’s technologies. But, as STAT reports, it is unclear how much Holmes will divulge as the company has no peer-reviewed data and is facing scrutiny from the federal government.

Cardiac Science releases new CPR support device

Cardiac Science, an external defibrillator manufacturer in Waukesha, Wisconsin, has launched a cardiopulmonary resuscitation device, aimed at improving the way emergency officials perform CPR.

Stryker recalls 167 angiographic catheters

Stryker Sustainability Solutions voluntarily recalled 167 of its Angiodynamics Soft Vu Omni Flush angiographic catheters on July 22.

Mitral valve repair device 100 percent successful in first human clinical study

Researchers at the University of Maryland School of Medicine have developed a device that has a 100 percent success rate in repairing the mitral heart valve in its first human clinical study, with results published in the journal Circulation.

Endotronix closes Series C round funding for development of artery sensor

Digital health company Endotronix has raised $32 million in its Series C round funding that will help finance development on its cloud-based patient management system and artery sensors.

Alere recalls its PT/INR monitoring system

Alere voluntarily recalled its INRatio and INRatio 2 prothrombin time/international normalized ratio (PT/INR) monitoring system, according to a July 12 announcement.

FDA approves St. Jude Medical’s CRT software

The FDA approved St. Jude Medical’s SyncAV cardiac resynchronization therapy (CRT) software July 11 for independent use or with the company’s MultiPoint pacing technology.

Pages